| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | 31-Oct-05 | | Total Revenue | 14,724,000 | 12,295,000 | 12,124,000 | | Cost of Revenue | 11,930,000 | 10,131,000 | 10,250,000 | | | Gross Profit | 2,794,000 | 2,164,000 | 1,874,000 | | | Operating Expenses | | Research Development | 380,000 | 382,000 | 413,000 | | Selling General and Administrative | 1,453,000 | 1,461,000 | 1,067,000 | | Non Recurring | 358,000 |
-
| (2,000) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 603,000 | 321,000 | 396,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14,000) | 34,000 | (33,000) | | Earnings Before Interest And Taxes | 660,000 | 429,000 | 453,000 | | Interest Expense | 469,000 | 502,000 | 308,000 | | Income Before Tax | 191,000 | (73,000) | 145,000 | | Income Tax Expense | 57,000 | 47,000 | 6,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 134,000 | (120,000) | 139,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 134,000 | (120,000) | 139,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $134,000 | ($120,000) | $139,000 |
|
1.48% Nasdaq 
Income Statement
